The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 62, Issue 7, 2010, Pages 2055-2063

  Brooks, William M ^a   Sibbitt Jr , Wilmer L ^b   Kornfeld, Mario ^b   Jung, Rex E ^b   Bankhurst, Arthur D ^b   Roldan, Carlos A ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; LACTIC ACID; LIPID; N ACETYLASPARTIC ACID;

ACETYLCHOLINE BRAIN LEVEL; ADULT; ARTICLE; ASTROCYTE; AUTOPSY; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INJURY; BRAIN METABOLISM; BRAIN REGION; CELL DENSITY; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYST; DISEASE ASSOCIATION; FEMALE; FIBRIN CLOT; GLIOSIS; HISTOPATHOLOGY; HUMAN; MACROPHAGE; MALE; MICROGLIA; NERVE CELL NECROSIS; NERVE FIBER; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGODENDROGLIA; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE AGGREGATION; THROMBOSIS; VASCULAR DISEASE;

ADULT; ASPARTIC ACID; BIOLOGICAL MARKERS; BRAIN; CHOLINE; CREATINE; FATAL OUTCOME; FEMALE; HEALTH STATUS; HUMANS; LACTIC ACID; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77954238842     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27458     Document Type: Article

References (50)

1. Kozora E, Arciniegas DB, Filley CM, West SG, Brown M, Miller D, et al. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. Arthritis Rheum 2008;59:1639-46.
2. Steens SC, Admiraal-Behloul F, Bosma GP, Steup-Beekman GM, Olofsen H, le Cessie S, et al. Selective gray matter damage in neuropsychiatric lupus; a magnetization transfer imaging study. Arthritis Rheum 2004;50:2877-81. (Pubitemid 39209525)
3. Bosma GP, Huizinga TW, Mooijaart SP, van Buchem MA. Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus. AJNR Am J Neuroradiol 2003;24: 850-4.
4. Sibbitt WL Jr, Schmidt PJ, Hart BL, Brooks WM. Fluid Attenuated Inversion Recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus. J Rheumatol 2003;30:1983-9.
5. Sibbitt WL Jr, Sibbitt RR. Magnetic resonance spectroscopy and positron emission tomography scanning in neuropsychiatric systemic lupus erythematosus. Rheum Dis Clin North Am 1993;19: 851-68.
6. Sibbitt WL Jr, Haseler LJ, Griffey RH, Hart BL, Sibbitt RR, Matwiyoff NA. Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy. AJNR Am J Neuroradiol 1994;15:923-8.
7. Brooks WM, Jung RE, Ford CC, Greinel EJ, Sibbitt WL Jr. Relationship between neurometabolite derangement and neurocognitive dysfunction in systemic lupus erythematosus. J Rheumatol 1999;26:81-5.
8. Davie CA, Feinstein A, Kartsounis LD, Barker GJ, McHugh NJ, Walport MJ, et al. Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system. J Neurol 1995;242:522-8.
9. Brooks WM, Sabet A, Sibbitt WL Jr, Barker PB, van Zijl PC, Duyn JH, et al. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J Rheumatol 1997;24:2323-9. (Pubitemid 28005130)
10. Chinn RJ, Wilkinson ID, Hall-Craggs MA, Paley MN, Shortall E, Carter S, et al. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:36-46. (Pubitemid 27044034)
11. Rozell CL, Sibbitt WL Jr, Brooks WM. Structural and neurochemical markers of brain injury in the migraine diathesis of systemic lupus erythematosus. Cephalalgia 1998;18:209-15.
12. 31P magnetic resonance spectroscopy. J Cereb Blood Flow Metab 1992;12:584-92.
13. Cheng LL, Newell K, Mallory AE, Hyman BT, Gonzalez RG. Quantification of neurons in Alzheimer and control brains with ex vivo high resolution magic angle spinning proton magnetic resonance spectroscopy and stereology. Magn Reson Imaging 2002;20: 527-33. (Pubitemid 35304038)
14. Tran T, Ross B, Lin A. Magnetic resonance spectroscopy in neurological diagnosis. Neurol Clin 2009;27:21-60, xiii.
15. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
16. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
17. Gladman D, Urowitz M, Fortin P, Isenberg D, Goldsmith C, Gordon C, et al. Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group. J Rheumatol 1996;23:1953-5. (Pubitemid 26376123)
18. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
19. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
20. Sibbitt WL Jr, Brandt JR, Johnson CR, Maldonado ME, Patel SR, Ford CC, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002;29:1536-42.
21. 1H-MRS study of normal human brain. Neuroimage 2005;26:965-72.
22. Murphy M, Loosemore A, Ferrer I, Wesseling P, Wilkins PR, Bell BA. Neuropathological diagnostic accuracy. Br J Neurosurg 2002; 16:461-4.
23. Nagaoka S, Matsunaga K, Chiba J, Ishigatsubo Y, Tani K. Five cases of systemic lupus erythematosus with intracranial calcification. Rinsho Shinkeigaku 1982;22:635-43. In Japanese.
24. Friedman SD, Stidley CA, Brooks WM, Hart BL, Sibbitt WL Jr. Brain injury and neurometabolic abnormalities in systemic lupus erythematosus. Radiology 1998;209:79-84.
25. Sibbitt WL Jr, Sibbitt RR, Brooks WM. Neuroimaging in neuropsychiatric systemic lupus erythematosus [review]. Arthritis Rheum 1999;42:2026-38.
26. Sabet A, Sibbitt WL, Jr., Stidley CA, Danska J, Brooks WM. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke 1998;29:2254-60. (Pubitemid 28511941)
27. Sibbitt WL Jr, Haseler LJ, Griffey RR, Friedman SD, Brooks WM. Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. AJNR Am J Neuroradiol 1997;18:1271-7.
28. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 1968;47: 337-69.
29. Funata N. Cerebral vascular changes in systemic lupus erythematosus. Bull Tokyo Med Dent Univ 1979;26:91-112. (Pubitemid 10223854)
30. Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum 1979;8:212-21.
31. Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 1988;23:380-4. (Pubitemid 18098245)
32. Hammad A, Tsukada Y, Torre N. Cerebral occlusive vasculopathy in systemic lupus erythematosus and speculation on the part played by complement. Ann Rheum Dis 1992;51:550-2.
33. Hanly JG, Walsh NM, Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol 1992;19:732-41.
34. Shiozawa S, Kuroki Y, Kim M, Hirohata S, Ogino T. Interferonalpha in lupus psychosis. Arthritis Rheum 1992;35:417-22.
35. Ellison D, Gatter K, Heryet A, Esiri M. Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus. J Clin Pathol 1993;46:37-40. (Pubitemid 23039584)
36. Koller KJ, Zaczek R, Coyle JT. N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem 1984;43: 1136-42. (Pubitemid 14011271)
37. Luyten PR, den Hollander JA. Observation of metabolites in the human brain by MR spectroscopy. Radiology 1986;161:795-8.
38. Sappey-Marinier D, Calabrese G, Hetherington HP, Fisher SN, Deicken R, Van Dyke C, et al. Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities. Magn Reson Med 1992;26:313-27.
39. Falk RJ, Dalmasso AP, Kim Y, Lam S, Michael A. Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus. N Engl J Med 1985; 312:1594-9.
40. Hopkins P, Belmont HM, Buyon J, Philips M, Weissmann G, Abramson SB. Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis. Arthritis Rheum 1988;31: 632-41.
41. Levine SR, Deegan MJ, Futrell N, Welch KM. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990;40:1181-9.
42. Sakaki T, Morimoto T, Utsumi S. Cerebral transmural angiitis and ruptured cerebral aneurysms in patients with systemic lupus erythematosus. Neurochirurgia (Stuttg) 1990;33:132-5.
43. Mitsias P, Levine SR. Large cerebral vessel occlusive disease in systemic lupus erythematosus. Neurology 1994;44:385-93.
44. Bruyn GA. Controversies in lupus: nervous system involvement. Ann Rheum Dis 1995;54:159-67.
45. Belmont HM, Abramson SB, Lie JT. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus: interactions of inflammatory cells and activated endothelium [review]. Arthritis Rheum 1996;39:9-22.
46. Shintaku M, Matsumoto R. Disseminated perivenous necrotizing encephalomyelitis in systemic lupus erythematosus: report of an autopsy case. Acta Neuropathol 1998;95:313-7.
47. Sibbitt WL Jr, Brooks WM, Haseler LJ, Griffey RH, Frank LM, Hart BL, et al. Spin-spin relaxation of brain tissues in systemic lupus erythematosus: a method for increasing the sensitivity of magnetic resonance imaging for neuropsychiatric lupus. Arthritis Rheum 1995;38:810-8.
48. Roldan CA, Gelgand EA, Qualls CR, Sibbitt WL Jr. Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus. Am J Cardiol 2005;95:1441-7.
49. Roldan CA, Gelgand EA, Qualls CR, Sibbitt WL Jr. Valvular heart disease is associated with nonfocal neuropsychiatric systemic lupus erythematosus. J Clin Rheumatol 2006;12:3-10.
50. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001;7:1189-93.